Novo Nordisk A/S
Time frame: 1 April 2023 - 31 March 2024Article ‘Count’ and ‘Share’ for Novo Nordisk A/S based on listed parameters only.
The articles listed below published by authors from Novo Nordisk A/S, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
| Journal | Count | Share |
|---|---|---|
|
Circulation |
1 | 0.20 |
|
Diabetes Care |
4 | 1.61 |
|
Hepatology |
1 | 0.27 |
|
International Journal of Obesity |
3 | 1.38 |
|
JAMA: The Journal of the American Medical Association |
1 | 0.33 |
|
Journal of Clinical Endocrinology & Metabolism |
3 | 0.69 |
|
Journal of Hepatology |
1 | 0.14 |
|
Journal of the American College of Cardiology |
2 | 0.27 |
|
Journal of the American Society of Nephrology |
1 | 0.06 |
|
Kidney International |
1 | 0.19 |
|
Nature |
1 | 0.05 |
|
Nature Communications |
1 | 0.00 |
|
Nature Medicine |
1 | 0.18 |
|
Science Advances |
1 | 0.02 |
|
The Lancet |
5 | 1.88 |
|
The Lancet Diabetes & Endocrinology |
2 | 0.75 |
|
The Lancet Neurology |
1 | 0.06 |
|
The New England Journal of Medicine |
4 | 1.10 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.